These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10228909)

  • 1. Using statistical process control charts for the continual improvement of asthma care.
    Boggs PB; Hayati F; Washburne WF; Wheeler DA
    Jt Comm J Qual Improv; 1999 Apr; 25(4):163-81. PubMed ID: 10228909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peak expiratory flow rate control chart in asthma care: chart construction and use in asthma care.
    Boggs PB; Wheeler D; Washburne WF; Hayati F
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):552-62. PubMed ID: 9892027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home peak expiratory flow rate monitoring in patients with asthma.
    Li JT
    Mayo Clin Proc; 1995 Jul; 70(7):649-56. PubMed ID: 7791387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma self-management education program by home monitoring of peak expiratory flow.
    Ignacio-Garcia JM; Gonzalez-Santos P
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):353-9. PubMed ID: 7842191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we monitor peak expiratory flow rates or record symptoms with a simple diary in the management of asthma?
    Malo JL; L'Archevêque J; Trudeau C; d'Aquino C; Cartier A
    J Allergy Clin Immunol; 1993 Mar; 91(3):702-9. PubMed ID: 8454792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies.
    Bheekie A; Syce JA; Weinberg EG
    J Clin Pharm Ther; 2001 Aug; 26(4):287-96. PubMed ID: 11493372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of immunotherapy on symptoms, PEFR, spirometry, and airway responsiveness in patients with allergic asthma to house-dust mites (D. pteronyssinus) on inhaled steroid therapy.
    Costa JC; Plácido JL; Silva JP; Delgado L; Vaz M
    Allergy; 1996 Apr; 51(4):238-44. PubMed ID: 8792920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between peak expiratory flow rates (PEFR) and FEV1 in the monitoring of asthmatic subjects at an outpatient clinic.
    Gautrin D; D'Aquino LC; Gagnon G; Malo JL; Cartier A
    Chest; 1994 Nov; 106(5):1419-26. PubMed ID: 7956394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reproducibility of peak expiratory flow rate measured at home].
    Nakashima A; Ikeda K; Tsukino M; Ikeda A; Fujita H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):956-60. PubMed ID: 2232380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirometric patterns in childhood asthma: peak flow compared with other indices.
    Klein RB; Fritz GK; Yeung A; McQuaid EL; Mansell A
    Pediatr Pulmonol; 1995 Dec; 20(6):372-9. PubMed ID: 8649917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible?
    van Schayck CP; van den Broek PJ; den Otter JJ; van Herwaarden CL; Molema J; van Weel C
    JAMA; 1995 Jul; 274(2):161-4. PubMed ID: 7596005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial of magnesium sulphate as a vehicle for nebulized salbutamol in the treatment of moderate to severe asthma attacks.
    Kokturk N; Turktas H; Kara P; Mullaoglu S; Yilmaz F; Karamercan A
    Pulm Pharmacol Ther; 2005; 18(6):416-21. PubMed ID: 15953743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control charts demonstrated limited utility for the monitoring of lung function in asthma.
    Turner RM; Hayen A; Macaskill P; Irwig L; Reddel HK
    J Clin Epidemiol; 2012 Jan; 65(1):53-61. PubMed ID: 21803547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIKO-1, an effective, handy device for the patient's personal PEFR and FEV1 electronic long-term monitoring.
    Dal Negro RW; Micheletto C; Tognella S; Turati C; Bisato R; Guerriero M; Sandri M; Turco P
    Monaldi Arch Chest Dis; 2007 Jun; 67(2):84-9. PubMed ID: 17695691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-between control charts for monitoring asthma attacks.
    Alemi F; Neuhauser D
    Jt Comm J Qual Saf; 2004 Feb; 30(2):95-102. PubMed ID: 14986340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children.
    Watanasomsiri A; Phipatanakul W
    Ann Allergy Asthma Immunol; 2006 May; 96(5):701-6. PubMed ID: 16729783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of self-efficacy, social support and knowledge on adherence to PEFR self-monitoring among adults with asthma: a prospective repeated measures study.
    Ngamvitroj A; Kang DH
    Int J Nurs Stud; 2007 Aug; 44(6):882-92. PubMed ID: 16620821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of nebulized ipratropium in severely asthmatic children.
    Qureshi F; Zaritsky A; Lakkis H
    Ann Emerg Med; 1997 Feb; 29(2):205-11. PubMed ID: 9018183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of inhaled triggering factors decreases prolonged drug therapy requirements in patients with asthma].
    Hernández M; Salmen S; Berrueta L; Navas M; Sánchez B; Muñoz J; Delgado R; Romano E; Rangel A
    Invest Clin; 2000 Mar; 41(1):3-18. PubMed ID: 10758695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.